Introduction
In recent years capillary abnormalities have been noted in many diseases, but the measurement of capillary fragility has been neglected as a clinical investigation, possibly because of the difficulties of the test, the available methods being time-consuming, uncomfortable for the patient, or difficult to interpret (Peck and Copley, 1946; Munro et al., 1947) . All methods of capillary fragility measurement depend on the appearance of petechiae, and this may vary with skin thickness, the site chosen, room temperature and humidity, as well as the extent and duration of the pressure applied. Also, as petechiae continue to appear after pressure has been released petechial counts are subject to considerable error.
With a standard technique it may be postulated that the number of petechiae seen at a given site depends on the pressure applied, its duration, and the capillary fragility. In the recognized methods pressure (positive or negative) and time are standardized, and a result is obtained by counting petechiae. We have devised a method for measuring the capillary fragility which does not depend on total petechial counts. It is based on the simultaneous application of positive and negative pressure. The time of appearance of a given number of petechiae is noted, and, as pressure is standardized, time is the measured variable.
Method
The apparatus is diagrammatically represented in Fig. 1 
Results

Capillary Fragility in Non-diabetics
The non-diabetic group consisted of 88 subjects. They comprised 50 women and 38 men aged 20 to 76 years. Although they were not physically examined, they were all apparently in good health and not receiving any treatment. Their capillary fragility was measured by the method described, and in 15 subjects the test was repeated after three months. The results were unchanged in 12 cases, and in the remaining three the variation in the end-point did not exceed 20 seconds.
The capillary fragility results were related to the subject's age (Fig. 2) . In the age groups 20 to 40 years the end-point to the test was reached within two minutes in only one subject out of 30. With increasing age the capillary fragility increased, and in the age groups 50 and over 12 out of 38 subjects developed more than six petechiae within two minutes.
Capillary Fragility in Diabetic Patients
The capillary fragility of 211 diabetic patients attending Salford Royal Hospital was measured on at least three occasions, at intervals over a two-year period. The patients comprised 117 women and 94 men. Thirty-two women were receiving insulin, 61 were taking tablets, and 24 were on diet alone. In the male group 41 were receiving insulin, 36 tablets, and 17 were on diet.
Patients were tested as the opportunity arose, and no special selection was made. However, the results presented apply only to patients who were considered to be stable diabetics, having two consecutive blood sugars of less than 300 mg./100 ml. at clinic attendance without change of treatment. Sixteen The capillary fragility 'results of the remaining 195 patients are given in Fig. 3 (1940, 1942) . This means that the limits of normality should be determined for each age group, but it is uncertain whether this is a valid assumption or whether it would be better to compare all subjects with an ideal normal capillary fragility based on the results obtained in the 20 to 40 age group. We have found it necessary therefore to avoid setting limits for normality, and have compared the capillary fragility in different groups merely by the time that has been taken to reach the endpoint, which is the appearance of six or more petechiae, in the standard conditions of the test.
When comparing our results in the diabetic and non-diabetic groups it is apparent that in diabetic patients the capillary fragility is in general increased in each age group. This is particularly apparent in the younger age groups. Almost all the young diabetics were treated with insulin, and, as is shown in Fig. 3 , many of these patients developed petechiae within one or two minutes. We have confirmed, therefore, that in general the capillary fragility is increased in patients with diabetes, as was observed by Rodriguez and Root (1948) , Barnes (1950), and Lundboek (1953) . Nevertheless, the proportion of the patients with fragile capillaries who also have complications of diabetes is striking, as shown in Fig. 3 , and our results indicate that a major factor in the overall incidence of increased capillary fragility in diabetics is the presence of patients with diabetic complications in the group.
When the type of treatment is considered it is evident that patients on insulin have the greatest incidence of increased capillary fragility compared with patients taking tablets or diet alone. The differences shown in the (Handelsman et al., 1952; British Medical journal, 1965; Moore and Frew, 1965) and the decrease in capillary fragility after hypophysectomy for diabetic retinopathy (Christensen, 1968) . A direct consequence of this is that the measurement of capillary fragility offers an indication by which we may be able to select those patients who are going to develop retinopathy or other complications, but, more important, by studying the effect of changes in the diabetic state on the capillary fragility it may be possible to identify those factors which are responsible for the development of microangiopathy. Thus it seems that patients requiring large doses of insulin have increased capillary fragility, and it is interesting to speculate about a possible link between an insulin antagonist and microangiopathy. The usefulness of capillary fragility measurement remains to be evaluated. It may be a non-specific test, as capillary abnormality is a feature of many diseases. Nevertheless, even as a non-specific test it may be of value in following a patient's progress and possibly assessing the prognosis and response to treatment. Our method is well suited to large-scale surveys and clinic screening procedures. It is quick, painless, repeatable, and over 1,500 estimations have been made in two years.
